Jin10 data reported on May 30th that Baili Tianheng announced that the company plans to issue A-share stocks to specific targets and raise no more than 3.764 billion yuan. After deducting issuance costs, the actual funds raised will be entirely used for innovative drug research and development projects.
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
Bailitianheng: Plans to raise no more than 3.764 billion yuan, all of which will be used for innovative drug research and development.
Jin10 data reported on May 30th that Baili Tianheng announced that the company plans to issue A-share stocks to specific targets and raise no more than 3.764 billion yuan. After deducting issuance costs, the actual funds raised will be entirely used for innovative drug research and development projects.